Literature DB >> 15737803

Opioid medication and driving ability.

Hans G Kress1, Birgit Kraft.   

Abstract

In many European countries the use of opioids for long-term treatment of nonmalignant pain has dramatically increased during the last decade in order to improve the patient's quality of life, to allow an active social life and the return to work. In modern society, driving is regarded as an essential activity of daily living. Since opioids are centrally acting drugs that may interfere with the ability of safely driving a motor vehicle, the question arises of whether or not and on which conditions patients under continuous opioid medication may be considered fit to drive. In this article the evidence from recent studies of opioid effects on driving ability of patients is reviewed. Based on these data, the prerequisites and restrictions for driving under chronic opioid medication are outlined and practical guidelines are proposed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15737803     DOI: 10.1016/j.ejpain.2004.05.010

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  12 in total

1.  Pharmacokinetics and behavioral effects of liposomal hydromorphone suitable for perioperative use in rhesus macaques.

Authors:  Lisa Krugner-Higby; Butch KuKanich; Brynn Schmidt; Timothy D Heath; Carolyn Brown
Journal:  Psychopharmacology (Berl)       Date:  2011-03-15       Impact factor: 4.530

2.  Morphine efficacy is altered in conditional HIV-1 Tat transgenic mice.

Authors:  Sylvia Fitting; Krista L Scoggins; Ruqiang Xu; Seth M Dever; Pamela E Knapp; William L Dewey; Kurt F Hauser
Journal:  Eur J Pharmacol       Date:  2012-05-30       Impact factor: 4.432

Review 3.  Opioids for the treatment of chronic non-cancer pain in older people.

Authors:  Walter Gianni; Moira Ceci; Silvia Bustacchini; Andrea Corsonello; Angela Marie Abbatecola; Anna Maria Brancati; Antonio Assisi; Angelo Scuteri; Luca Cipriani; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

4.  Association of obstructive sleep apnea and opioids use on adverse health outcomes: A population study of health administrative data.

Authors:  Tetyana Kendzerska; Tara Gomes; Atul Malhotra; Andrea S Gershon; Marcus Povitz; Daniel I McIsaac; Shawn D Aaron; Frances Chung; Gregory L Bryson; Robert Talarico; Tahmid Ahmed; Michael Godbout; Peter Tanuseputro
Journal:  PLoS One       Date:  2022-06-28       Impact factor: 3.752

Review 5.  Medication use and the risk of motor vehicle collisions among licensed drivers: A systematic review.

Authors:  Toni M Rudisill; Motao Zhu; George A Kelley; Courtney Pilkerton; Brandon R Rudisill
Journal:  Accid Anal Prev       Date:  2016-08-29

Review 6.  Social media and pharmacovigilance: A review of the opportunities and challenges.

Authors:  Richard Sloane; Orod Osanlou; David Lewis; Danushka Bollegala; Simon Maskell; Munir Pirmohamed
Journal:  Br J Clin Pharmacol       Date:  2015-09-02       Impact factor: 4.335

7.  Acute administration of oxycodone, alcohol, and their combination on simulated driving-preliminary outcomes in healthy adults.

Authors:  Shanna Babalonis; Marion A Coe; Paul A Nuzzo; Michelle R Lofwall; Nur Ali; Paul A Sloan; Laura C Fanucchi; Sharon L Walsh
Journal:  Psychopharmacology (Berl)       Date:  2020-11-09       Impact factor: 4.530

8.  Driving Ability in Patients with Severe Chronic Low Back or Osteoarthritis Knee Pain on Stable Treatment with Tapentadol Prolonged Release: A Multicenter, Open-label, Phase 3b Trial.

Authors:  Rainer Sabatowski; Rüdiger Scharnagel; Anne Gyllensvärd; Ilona Steigerwald
Journal:  Pain Ther       Date:  2014-04-04

9.  Prevalence and Predictors of Driving after Prescription Opioid Use in an Adult ED Sample.

Authors:  Aaron D Dora-Laskey; Jason E Goldstick; Brooke J Arterberry; Suni Jo Roberts; Rebecca L Haffajee; Amy S B Bohnert; Rebecca M Cunningham; Patrick M Carter
Journal:  West J Emerg Med       Date:  2020-06-19

10.  Opioid and chronic non-cancer pain.

Authors:  Sameer Gupta; Robert Atcheson
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.